Literature DB >> 29737249

Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development.

Mark R Swingle1, Richard E Honkanen1.   

Abstract

BACKGROUND: The reversible phosphorylation of proteins regulates many key functions in eukaryotic cells. Phosphorylation is catalyzed by protein kinases, with the majority of phosphorylation occurring on side chains of serine and threonine residues. The phosphomonoesters generated by protein kinases are hydrolyzed by protein phosphatases. In the absence of a phosphatase, the half-time for the hydrolysis of alkyl phosphate dianions at 25º C is over 1 trillion years; knon ~2 x 10-20 sec-1. Therefore, ser/thr phosphatases are critical for processes controlled by reversible phosphorylation.
METHODS: This review is based on the literature searched in available databases. We compare the catalytic mechanism of PPP-family phosphatases (PPPases) and the interactions of inhibitors that target these enzymes.
RESULTS: PPPases are metal-dependent hydrolases that enhance the rate of hydrolysis ([kcat/kM]/knon ) by a factor of ~1021, placing them among the most powerful known catalysts on earth. Biochemical and structural studies indicate that the remarkable catalytic proficiencies of PPPases are achieved by 10 conserved amino acids, DXH(X)~26DXXDR(X)~20- 26NH(X)~50H(X)~25-45R(X)~30-40H. Six act as metal-coordinating residues. Four position and orient the substrate phosphate. Together, two metal ions and the 10 catalytic residues position the phosphoryl group and an activated bridging water/hydroxide nucleophile for an inline attack upon the substrate phosphorous atom. The PPPases are conserved among species, and many structurally diverse natural toxins co-evolved to target these enzymes.
CONCLUSION: Although the catalytic site is conserved, opportunities for the development of selective inhibitors of this important group of metalloenzymes exist. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Phosphatase; cantharidin; fostriecin; inhibitor; microcystin crystal structures; okadaic acid; tautomycin.

Mesh:

Substances:

Year:  2019        PMID: 29737249     DOI: 10.2174/0929867325666180508095242

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I.

Authors:  Zachary R Woydziak; A John Yucel; A Richard Chamberlin
Journal:  ChemMedChem       Date:  2020-12-10       Impact factor: 3.466

2.  Targeting phosphatases in cancer: suppression of many versus the ablation of one.

Authors:  Brandon M D'Arcy; Aishwarya Prakash; Richard E Honkanen
Journal:  Oncotarget       Date:  2019-11-12

3.  The Serine/Threonine Protein Phosphatase 2A (PP2A) Regulates Syk Activity in Human Platelets.

Authors:  Stephanie Makhoul; Elena Kumm; Pengyu Zhang; Ulrich Walter; Kerstin Jurk
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

4.  Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth.

Authors:  Leia C Shuhaibar; Nabil Kaci; Jeremy R Egbert; Thibault Horville; Léa Loisay; Giulia Vigone; Tracy F Uliasz; Emilie Dambroise; Mark R Swingle; Richard E Honkanen; Martin Biosse Duplan; Laurinda A Jaffe; Laurence Legeai-Mallet
Journal:  JCI Insight       Date:  2021-05-10

5.  The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.

Authors:  Elena J Kumm; Oliver Pagel; Stepan Gambaryan; Ulrich Walter; René P Zahedi; Albert Smolenski; Kerstin Jurk
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.